-
Posted by
Two Blokes Jun 12 -
Filed in
Stock
-
10 views
Cochlear Ltd has lowered its earnings guidance amid slower-than-expected sales growth, just as it unveils the Nucleus Nexa System, its world-first smart cochlear implant with upgradeable firmware. While the guidance revision initially sent shares down by nearly 9%, the stock has since rebounded, as investors weigh the potential of the new technology alongside the company's updated financial outlook.
